FDA Drug Recalls

Recalls / Class III

Class IIID-1038-2017

Product

Pravastatin Sodium Tablets, USP, 10 mg, packaged in a) 90-count bottles (NDC 55111-229-90) and b) 500-count bottles (NDC 55111-229-05), Rx only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA; Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA.

Brand name
Pravastatin Sodium
Generic name
Pravastatin Sodium
Active ingredient
Pravastatin Sodium
Route
Oral
NDCs
55111-229, 55111-230, 55111-231, 55111-274
FDA application
ANDA076714
Affected lot / code info
Lot #: a) C700220, Exp 06/18; b) C700220, Exp 06/18

Why it was recalled

Failed Impurities/Degradation Specifications: high out of specification results for related impurity for lot C700220.

Recalling firm

Firm
Dr. Reddy's Laboratories, Inc.
Manufacturer
Dr.Reddy's Laboratories Limited
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
107 College Rd E, N/A, Princeton, New Jersey 08540-6623

Distribution

Quantity
544 bottles
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2017-07-11
FDA classified
2017-07-31
Posted by FDA
2017-08-09
Terminated
2019-04-01
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1038-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.